Fungal Infection Drugs: Introduction
- A fungal infection is also known as mycosis. It is a skin disease caused by a fungus. There are a million species of fungi.
- Fungi live on household surfaces, on plants, in dirt, and on skin of a human being
- The symptoms of fungal infections depend on the type of fungal infection. The most common symptoms include itching and skin changes, including red and possibly peeling or cracking skin.
Read Report Overview -
https://www.transparencymarketresearch.com/fungal-infection-drugs-market.html
- Fungal infections can occur anywhere on the body. Some of the most common fungal infections are ringworm, also known as tinea corporis, jock itch, athlete’s foot, and yeast infections.
- Fungal infections can be treated with anti-fungal medications. These medications can either kill fungi directly or prevent them from thriving and growing. Antifungal medications are available as prescription medications or over-the-counter (OTC) medications. Antifungal drugs are available in various formulations including powder, pills, sprays, shampoos, and creams or ointments.
- In addition to taking prescription medications or over-the-counter (OTC) antifungals, there are few things that patients can do at home to get rid of fungal infections, which include keeping the affected area clean and dry, and wearing loose-fitting shoes or clothing
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78918
Key Drivers of Global Fungal Infection Drugs Market
- Rise in prevalence of chronic diseases is projected to drive the global fungal infection drugs market during the forecast period. People with chronic diseases and weak immune responses such as cancer and AIDS are more susceptible to fungal infections.
- According to the Centers for Disease Control and Prevention, an estimated 220,000 new cases of cryptococcal meningitis occur globally each year, and about 181,000 deaths occur due to cryptococcal meningitis. Cryptococcal meningitis is a deadly brain infection caused by the soil-dwelling fungus Cryptococcus.
- According to a study published in the Lancet Infectious Diseases Journal 2019, fungi are the largest contributors to the opportunistic infections that affect patients with HIV
Azoles Segment to Dominate Global Fungal Infection Drugs Market
- In terms of drug class, the global fungal infection drugs market can be divided into azoles, echinocandins, polyenes, allylamines, and others
- Azoles can be segregated into voriconazole (Vfend), posaconazole (Noxafil), clotrimazole (Canesten), isavuconazole (CRESEMBA), and others
- Echinocandins can be split into caspofungin (Cancidas), micafungin (Mycamine/Funguard), and others
- Polyenes can be categorized into amphotericin (AmBisome) and others
- Allylamines can be classified into terbinafine (Lamisil) and others
- The azoles segment is anticipated dominate the global fungal infection drugs market during the forecast period due to broad-spectrum activity delivered by azoles
Request for Analysis of COVID-19 Impact on Fungal Infection Drugs Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78918
Retail Pharmacies Segment to Offer Attractive Opportunities
- Based on end-user, the global fungal infection drugs market can be divided into hospital pharmacies, retail pharmacies, and others
- The retail pharmacies segment is expected to offer significant opportunities during the forecast period. The segment’s dominance can be attributed to the large volume of sales of fungal infection drugs through retail channel.
North America to Dominate Global Fungal Infection Drugs Market
- In terms of region, the global fungal infection drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is projected to dominate the global fungal infection drugs market during the forecast period. The region’s dominance can be attributed to increase in incidence of infectious diseases in countries such as the U.S. and Canada.
Pre Book Fungal Infection Drugs Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=78918<ype=S
Key Players Operating in Global Fungal Infection Drugs Market
The global fungal infection drugs market is consolidated, with the presence of international and few local players. Key players operating in the global fungal infection drugs market are:
- Enzon Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals
- Abbott Laboratories
- Astellas Pharma, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Bayer AG
- Novartis AG
- Pfizer, Inc.
More Trending Reports by Transparency Market Research –
Healthcare Automation Market:
Radiopharmaceutical Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
